Alan S. Roemer - 04 Oct 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
04 Oct 2024
Net transactions value
$0
Form type
4
Filing time
08 Oct 2024, 16:15:10 UTC
Previous filing
14 Jun 2024
Next filing
23 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +126,582 +80% 285,030 04 Oct 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Disposed to Issuer -102,459 -100% 0 04 Oct 2024 Common Stock 102,459 $1.25 Direct F2, F3, F4
transaction INAB Series A Warrants (right to buy) Award +102,459 102,459 04 Oct 2024 Common Stock 102,459 $0.4500 Direct F2, F3, F4
transaction INAB Series C Warrants (right to buy) Award +126,582 126,582 04 Oct 2024 Common Stock 126,582 $0.2700 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.
F2 The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
F3 Fully vested and exercisable.
F4 The reported securities are included within 102,459 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.